Abbott Laboratories (ABT) stock forecast — our track record

Lyra published 13 ABT stock forecasts beginning July 11, 2025. Every prediction was published before its outcome was known, then closed and scored after its forecast window ended. All 13 used the short term (0 to 3 months) horizon. The final window ended October 15, 2026.

Five forecasts reached their targets, while 8 earned partial credit. None of them missed. The average success score was 65.4%. Since every call covered the same short-term horizon, there was no medium-term or long-term result to compare. The short-term calls also had an average peak gain of 7%.

The best call was published July 16, 2026. It predicted 13% growth, and the stock rose as much as 16.9%. The target was reached in 33 days, and the call earned a 100% score. The weakest call was published January 6, 2026. It predicted 10% growth, but the stock rose only 0.9% at its peak and did not reach the target. That call received a 50% score. Overall, the track record was mixed: five targets were reached, 8 calls received partial credit, and there were no misses.